Jubilant Ingrevia Board Approves Unaudited Financial Results for Q2 2026
Jubilant Ingrevia’s Board of Directors approved the unaudited financial results for the quarter and half-year ended September 30, 2025.…
Tata Consumer Products Board Meeting to Discuss Quarterly Results
Tata Consumer Products has scheduled a board meeting on November 3, 2025, to review and approve the unaudited standalone and consolidated…
TBO Tek Board to Consider Financial Results on November 3, 2025
The Board of Directors of TBO Tek is scheduled to meet on November 3, 2025, to consider and approve the unaudited standalone and consolidated…
Indian Hotels Board to Consider Un-Audited Financial Results on November 4, 2025
The Board of Directors of Indian Hotels Company Limited will convene on November 4, 2025, to review and approve the Un-Audited (Reviewed)…
GlaxoSmithKline Un-Audited Financial Results for Q2 & Half Year Ended September 30, 2025
GlaxoSmithKline Pharmaceuticals Limited will hold a meeting of the Board of Directors on November 6, 2025, to consider and approve the…
Grasim Industries Board Meeting Scheduled to Approve Unaudited Financial Results
Grasim Industries has announced a board meeting scheduled for November 5, 2025, to review and approve the unaudited financial results for the…
Tata Investment Corporation Unaudited Financial Results for Quarter Ended September 30, 2025
Tata Investment Corporation announced its unaudited standalone and consolidated financial results for the quarter ended September 30, 2025.…
Sumitomo Chemical India Unaudited Financial Results for Quarter Ended September 30, 2025
Sumitomo Chemical India announced its unaudited financial results for the quarter ended September 30, 2025. The company reported a total…
Supreme Industries Interim Dividend Declared Amid Strong Q2 Results
Supreme Industries has announced an interim dividend of ₹11 per share alongside strong financial results for the second quarter of FY26. The…
PTC India Board Meeting Scheduled for November 11, 2025
PTC India has announced a board meeting scheduled for November 11, 2025, to consider and approve the unaudited standalone and consolidated…